YM201636
YM201636 is a potent, selective and cell-permeable inhibitor of mammalian class III phosphatidylinositol phosphate kinase PIKfyve with IC50 value of 33nM [1].
The pyridofuropyrimidine compound, YM201636, is a small-molecule inhibitor of PIKfyve. In the in vitro assay, it inhibits PIKfyve with IC50 value of 33nM and shows no inhibition of yeast orthologue of PIKfyve. It inhibits PtdIns3P p110α and type Iα PtdInsP kinase with IC50 values of 3μM and > 2μM, respectively. The type IIγ PtdInsP kinase is found to be insensitive to YM201636. In serum-starved NIH3T3 cells, YM201636 inhibits PtdIns (3, 5) P2 production by 80% at concentration of 800nM. Acute treatment of YM201636 to MEFs, MDCK, MCF10A, COS7 and NIH3T3 cells causes the formation of large vesicular structures. Besides that, YM201636 is also found to reduce the Akt phosphorylation and GLUT4 cell surface translocation through inhibiting the insulin-dependent class I PI 3k activation [1, 2].
References:
[1] Jefferies H B J, Cooke F T, Jat P, et al. A selective PIKfyve inhibitor blocks PtdIns (3, 5) P2 production and disrupts endomembrane transport and retroviral budding. EMBO reports, 2008, 9(2): 164-170.
[2] Ikonomov O C, Sbrissa D, Shisheva A. YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns (3, 5) P2synthesis, halts glucose entry by insulin in adipocytes. Biochemical and biophysical research communications, 2009, 382(3): 566-570.
| Physical Appearance | A solid |
| Storage | Store at -20°C |
| M.Wt | 467.48 |
| Cas No. | 371942-69-7 |
| Formula | C25H21N7O3 |
| Solubility | insoluble in H2O; insoluble in EtOH; ≥11.68 mg/mL in DMSO |
| Chemical Name | 6-amino-N-[3-(4-morpholin-4-ylpyrido[2,3]furo[2,4-b]pyrimidin-2-yl)phenyl]pyridine-3-carboxamide |
| SDF | Download SDF |
| Canonical SMILES | C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |
| Cell experiment [1, 2]: | |
|
Cell lines |
Mouse 3T3L1 adipocytes, NIH3T3 cells |
|
Preparation method |
The solubility of this compound in DMSO is >11.7mg/mL. General tips for obtaining a higher concentration: Please warm the tube at 37℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
|
Reacting condition |
0-4 μM for 30 min or 800 nM for 2h |
|
Applications |
In mouse 3T3L1 adipocytes, YM201636 significantly inhibited both basal and insulin-activated 2DG uptake in a dose-dependent way. YM201636 (160 nM) nearly completely inhibited the net insulin effect with a 50% inhibition at 54 ± 4 nM. YM201636 at 800 nM produced a 45% inhibition of cell surface HA-GLUT4-eGFP accumulation and a 55% inhibition of Akt-Ser473 phosphorylation. In NIH3T3 cells, YM201636 at 800 nM decreased PtdIns(3,5)P2 production by 80%. YM201636 induced the vesiculation phenotype by affecting PIKfyve and PtdIns(3,5)P2 production. |
|
References: [1] Jefferies H B J, Cooke F T, Jat P, et al. A selective PIKfyve inhibitor blocks PtdIns (3, 5) P2 production and disrupts endomembrane transport and retroviral budding. EMBO reports, 2008, 9(2): 164-170. [2]. Ikonomov O C, Sbrissa D, Shisheva A. YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns (3, 5) P2synthesis, halts glucose entry by insulin in adipocytes. Biochemical and biophysical research communications, 2009, 382(3): 566-570. | |
| Description | YM201636 is a selective inhibitor of PIKfyve with an IC50 value of 33 nM. | |||||
| Targets | PIKfyve | p110α | ||||
| IC50 | 33 nM | 3.3 μM | ||||
Quality Control & MSDS
- View current batch:
Chemical structure
